98%
921
2 minutes
20
Objectives: The aim of this study was to determine the sonographic features, antenatal course, and pregnancy outcome in pregnancies in which a placental cyst (PC) or a placental atypical sonolucency (PAS) was identified at the routine first-trimester scan.
Methods: Pregnancies in which a first-trimester PC/PAS was sonographically detected at 11-13 weeks' gestation were recruited. Relevant information was obtained by reviewing ultrasound reports and medical records.
Results: A PC/PAS was identified in 12 of 8150 first-trimester pregnancies undergoing sonographic screening (prevalence 1/679; 0.15%). Median gestational age at evaluation was 13 weeks + 3 days (range, 11 + 1-13 + 6). Monochorionic twin pregnancy was detected in one case. Median cyst diameter was 11 mm (range, 7-26). The cyst was single in 10 cases (83%) and multiple in the other two (17%). Four (33%) were eccentric and eight (67%) were central in location. Except for three pregnancies complicated with multiple major anomalies, the prognosis was universally good in the remaining cases, with resolution or spontaneous involution in all continuing pregnancies.
Conclusions: A PC/PAS is an uncommon finding during the 11-13 weeks scan. It is often incidental, transient, and according to our experience of no clinical significance in isolated cases. When detected in fetuses with congenital anomalies, the final prognosis depends on the associated fetal malformations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jcu.23984 | DOI Listing |
JMIR Res Protoc
September 2025
Gender and Women's Health Unit, Nossal Institute for Global Health, School of Population and Global Health, The University of Melbourne, Carlton, Australia.
Background: Assisted vaginal birth is a lifesaving procedure where health workers use special devices to expedite birth vaginally when some complications emerge, such as due to prolonged labor. When the use of assisted vaginal birth is possible and appropriate, it provides benefits over cesarean section. These benefits include shorter recovery, reduced hospital stays, lower risks of complications, cost savings, and greater likelihood of vaginal birth in future pregnancies.
View Article and Find Full Text PDFJAMA Pediatr
September 2025
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Importance: Neonatal intensive care has advanced over recent decades, yet premature birth remains associated with increased neonatal mortality and morbidity.
Objective: To describe health service use, morbidity, and medication needs up to age 5 years in a contemporary cohort of children born preterm.
Design, Setting, And Participants: This population-based cohort study was conducted in British Columbia (BC), Canada, using health service and pharmacy data linked using provincial administrative databases.
JAMA Pediatr
September 2025
Department of Anthropology, University of Oregon, Eugene.
JAMA
September 2025
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University Providence, Rhode Island.
JAMA
September 2025
Department of Obstetrics and Gynecology, Máxima Medical Center, Veldhoven, the Netherlands.
Importance: Pregnant individuals with polycystic ovary syndrome (PCOS) present with a higher risk of pregnancy complications, including gestational diabetes, preeclampsia, and preterm birth. Myo-inositol supplementation may reduce these risks.
Objective: To determine whether daily supplementation with myo-inositol during pregnancy among individuals with PCOS reduces the risk of a composite outcome of gestational diabetes, preeclampsia, and preterm birth.